Xilio Therapeutics

Xilio Therapeutics is a biotechnology company. They offer cancer immunotherapies designed to improve patient outcomes by unleashing the power of the immune system selectively at the site of the tumor. Their tumor-selective immunotherapies are based on its proprietary technology, which maximizes the potency of proven immuno-oncology therapies and restricts their activity to the tumor to minimize peripheral side effects.

Domain

xiliotx.com

Industry

Biopharma

Employees

51-100

Last Funding

$35.8M

Founded

2015

Frequently Asked Questions

What technologies does Xilio Therapeutics use?+

Xilio Therapeutics uses 15 technologies including Bootstrap, Google Analytics, Google Tag Manager.

What industry is Xilio Therapeutics in?+

Xilio Therapeutics operates in the Biopharma industry.

Where is Xilio Therapeutics based?+

Xilio Therapeutics is headquartered in United States.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026